Pirfenidone 267 mg/1 (Pirfenidone TABLET, FILM COATED) 267 mg/1

Pirfenidone 267 mg tablets are used to manage certain lung conditions. This medication is designed to help improve lung function and reduce symptoms. Learn more about Pirfenidone uses and benefits.

Strength

267 mg/1

Pack Size

3 BOTTLE in 1 CARTON (31722-872-27) / 90 TABLET, FILM COATED in 1 BOTTLE (31722-872-90)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pirfenidone is commonly used to treat idiopathic pulmonary fibrosis (IPF), a chronic lung disease. It works by reducing inflammation and slowing the progression of lung damage. People often ask, 'What is Pirfenidone used for?' It is primarily prescribed for conditions that involve scarring of the lung tissue, helping to maintain lung function over time.

Side Effects

Common effects of Pirfenidone may include gastrointestinal issues such as nausea and diarrhea. Some users also report skin sensitivity to sunlight. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Pirfenidone should be handled with care, especially regarding sunlight exposure, as it can increase skin sensitivity. It is important to follow the advice of a healthcare provider when starting this medication. Always store Pirfenidone in a cool, dry place away from direct sunlight.

Avoid Interactions

Pirfenidone may interact with certain medications, including those metabolized by the liver's CYP1A2 enzyme. It is advisable to discuss all current medications with a healthcare provider before starting Pirfenidone. Avoiding alcohol and other substances that can affect liver function is also recommended.

Frequently Asked Questions

Pirfenidone is primarily used to treat idiopathic pulmonary fibrosis (IPF), a condition that causes scarring of the lung tissue.

Pirfenidone should be stored in a cool, dry place away from direct sunlight to maintain its effectiveness.

Common side effects may include nausea, diarrhea, and increased skin sensitivity to sunlight.

Pirfenidone may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Yes, Pirfenidone is available in various strengths, including 267 mg tablets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.